The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world multicentre analysis of patients with hepatocellular carcinoma (HCC) treated with atezolizumab and bevacizumab (A+B): Efficacy, esophagogastroduodenoscopy (EGD) uptake and bleeding complications.
 
Cha Len Lee
No Relationships to Disclose
 
Mark Freeman
No Relationships to Disclose
 
Conor O'Donnell
No Relationships to Disclose
 
Gordon Taylor Moffat
No Relationships to Disclose
 
Ekaterina Kosyachkova
No Relationships to Disclose
 
Hanna Lyubetska
No Relationships to Disclose
 
Brandon M. Meyers
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Purdue Pharma; Roche Canada
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis/Ipsen (Inst); Galera Therapeutics (Inst); GlaxoSmithKline Canada (Inst); H3 Biomedicine (Inst); SillaJen (Inst)
Expert Testimony - Eisai; Roche Canada
Travel, Accommodations, Expenses - Eisai; Merck Serono
 
Vallerie Lynn Gordon
Consulting or Advisory Role - AAA Canada; Incyte; Knight Therapeutics
 
Philip Q. Ding
No Relationships to Disclose
 
Aileigh Kay
No Relationships to Disclose
 
Roxana Bucur
No Relationships to Disclose
 
Winson Y. Cheung
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - AstraZeneca; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Vincent C. Tam
Honoraria - AstraZeneca; Eisai; Incyte; Ipsen; Roche Canada
Research Funding - AstraZeneca (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Merck (Inst); Roche Canada (Inst)
Expert Testimony - AstraZeneca Canada; Incyte